Post-Operative Pain – Pipeline Review, H1 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Post-Operative
Pain – Pipeline Review, H1 2019” drug pipelines has been added
to ResearchAndMarkets.com’s offering.

This latest Pharmaceutical and Healthcare disease pipeline guide
provides an overview of the Post-Operative Pain (Central Nervous System)
pipeline landscape.

Pain is one of the main postoperative adverse outcomes causing distress
to patients. The degree of postoperative pain experienced by individuals
varies. The cause of pain includes peripheral nerve damage during
surgery, inflammation at the site of the wound and damage to bodily
tissues during surgery. Risk factors include site of the operation, age,
level of fear or anxiety, surgical procedure, personal preference and
response to agents given. Treatment for post-operative pain includes
analgesia and anesthetics.

The Post-Operative Pain (Central Nervous System) pipeline guide also
reviews key players involved in therapeutic development for
Post-Operative Pain and features dormant and discontinued projects. The
guide covers therapeutics under Development by
Companies/Universities/Institutes, the molecules developed by Companies
in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II,
Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 2,
4, 8, 22, 9, 4, 32, 2 and 1 respectively. Similarly, the Universities
portfolio in Phase III and Preclinical stages comprises 1 and 3
molecules, respectively.

The Post-Operative Pain (Central Nervous System) pipeline guide helps in
identifying and tracking emerging players in the market and their
portfolios, enhances decision making capabilities and helps to create
effective counter strategies to gain competitive advantage.

Scope

• The pipeline guide provides a snapshot of the global therapeutic
  landscape of Post-Operative Pain (Central Nervous System).
• The pipeline guide reviews pipeline therapeutics for Post-Operative
  Pain (Central Nervous System) by companies and universities/research
  institutes based on information derived from company and
  industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of
  development ranging from pre-registration till discovery and
  undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline
  products which comprise, product description, descriptive licensing
  and collaboration details, R&D brief, MoA & other developmental
  activities.
• The pipeline guide reviews key companies involved in Post-Operative
  Pain (Central Nervous System) therapeutics and enlists all their major
  and minor projects.
• The pipeline guide evaluates Post-Operative Pain (Central Nervous
  System) therapeutics based on mechanism of action (MoA), drug target,
  route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued
  pipeline projects.
• The pipeline guide reviews latest news related to pipeline
  therapeutics for Post-Operative Pain (Central Nervous System)

Key Topics Covered:

• Post-Operative Pain – Overview
• Post-Operative Pain – Therapeutics Development
• Post-Operative Pain – Therapeutics Assessment
• Post-Operative Pain – Companies Involved in Therapeutics Development
• Post-Operative Pain – Drug Profiles
• Post-Operative Pain – Dormant Projects
• Post-Operative Pain – Discontinued Products
• Post-Operative Pain – Product Development Milestones

Companies Mentioned

• Abide Therapeutics Inc
• AcelRx Pharmaceuticals Inc
• Adynxx Inc
• AngioChem Inc
• Cadila Healthcare Ltd
• Camurus AB
• Cara Therapeutics Inc
• Cellix Bio Pvt Ltd
• CerSci Therapeutics Inc
• Cytogel Pharma LLC
• Dompe Farmaceutici SpA
• DURECT Corp
• Grunenthal GmbH
• Heron Therapeutics Inc
• Immupharma Plc
• Innocoll AG
• MedinCell SA
• Medtronic Plc
• Mundipharma International Ltd
• Neumentum Inc
• Novartis AG
• Ocular Therapeutix Inc
• Pacira Pharmaceuticals Inc
• PainReform Ltd
• Pharmaleads SA
• PhytoHealth Corp
• PixarBio Corp
• PolyPid Ltd
• RaQualia Pharma Inc
• Recro Pharma Inc
• Rottapharm Biotech Srl
• Serina Therapeutics Inc
• Taiwan Liposome Co Ltd
• Teikoku Pharma USA Inc
• Trevena Inc
• Xigen SA
• YiChang Humanwell Pharmaceutical Co Ltd

For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/oa26b1

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Analgesics